Form 8-K - Current report:
SEC Accession No. 0001641172-25-016681
Filing Date
2025-06-26
Accepted
2025-06-26 16:58:26
Documents
13
Period of Report
2025-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 42488
2 EX-99.1 ex99-1.htm EX-99.1 16339
  Complete submission text file 0001641172-25-016681.txt   231765

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE exoz-20250626.xsd EX-101.SCH 3014
4 XBRL LABEL FILE exoz-20250626_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE exoz-20250626_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3767
Mailing Address 750 ROYAL OAKS DR MONROVIA CA 91016
Business Address 750 ROYAL OAKS DR MONROVIA CA 91016 (626) - 415 - 1488
EXOZYMES INC. (Filer) CIK: 0002010788 (see all company filings)

EIN.: 834550057 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42204 | Film No.: 251081120
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)